Source: http://www.michaelgeist.ca/2017/11/rethinking-ip-in-the-tpp/ Years of disappointment in trade negotiations have left many Canadian intellectual property watchers hoping for the best, but expecting the worst when it comes to the IP provisions in trade deals. In earlier talks, Canadian negotiators would often advocate … Continue reading
PRESS RELEASE | 20 April 2016 | New Delhi RCEP: ASIA’S MEGA-REGIONAL FTA MEANS MEGA IMPACTS FOR PEOPLE IN INDIA AND THE REGION As the 12th round of trade negotiations for the RCEP commence in Perth (Australia) from 22 April … Continue reading
By Richard Trumka, The Hill| February 2, 2016 As a dozen nations gather in New Zealand this week to officially sign the Trans-Pacific Partnership (TPP), working families in the United States are sounding the alarm on a deal that would … Continue reading
By Matthew Driskill, FiercePharmaAsia |February 5, 2016 As expected and as FiercePharmaAsia reported in October 2015, provisions in the torturously negotiated Trans-Pacific Partnership (TPP) trade pact that deal with the exclusive period on biologics look set to derail plans to … Continue reading
Atty Mel Libre, Sunstar| Feb 6, 2016 IT WOULD have been like another working day in Auckland if not for the 5,000-plus protesters that created a commotion outside Sky City Hotel where ministers from 12 countries, including New Zealand, signed … Continue reading
The Wire; November 9, 2015. The substantial new barriers against generic entry envisaged by the TPP will not only ensure longer monopoly pricing for pharmaceutical products but also render competition between brand and generic manufacturers unviable.
Knowledge Ecology International; November 5, 2015. The negotiators have finally released, for the first time, TPP text, which is on the web here. Despite assurances from the contrary by Australia and USTR, intellectual property is a covered asset subject to Investor State … Continue reading